In the latter study, Batsios et al. used a dual PI3K/mTOR inhibitor XL765 and observed growth inhibition in mutant IDH1 overexpressing normal human astrocytes (NHA) and U87 GBM cells [81]. This evidence concerns the gene IDH1 and glioblastoma.